Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.600 | 0.680 | 6 | 31574705 | upstream gene variant | C/T | snv | 8.5E-02 |
|
0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Infections; Immune System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.608 | 0.760 | 6 | 31574531 | upstream gene variant | T/C | snv | 0.19 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Respiratory Tract Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.701 | 0.480 | 6 | 31574699 | upstream gene variant | C/A | snv | 0.14 |
|
Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.600 | 0.680 | 6 | 31574705 | upstream gene variant | C/T | snv | 8.5E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.776 | 0.320 | 6 | 31572779 | missense variant | T/C | snv | 0.27 | 0.27 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.732 | 0.320 | 6 | 31572364 | 5 prime UTR variant | A/C | snv | 0.64 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.732 | 0.320 | 6 | 31572364 | 5 prime UTR variant | A/C | snv | 0.64 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.701 | 0.480 | 6 | 31574699 | upstream gene variant | C/A | snv | 0.14 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 6 | 31571991 | upstream gene variant | A/G | snv | 0.69 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.701 | 0.480 | 6 | 31574699 | upstream gene variant | C/A | snv | 0.14 |
|
Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.608 | 0.760 | 6 | 31574531 | upstream gene variant | T/C | snv | 0.19 |
|
Respiratory Tract Diseases; Immune System Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.600 | 0.680 | 6 | 31574705 | upstream gene variant | C/T | snv | 8.5E-02 |
|
0.700 | 0 | |||||||||||
|
0.600 | 0.680 | 6 | 31574705 | upstream gene variant | C/T | snv | 8.5E-02 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||||
|
0.608 | 0.760 | 6 | 31574531 | upstream gene variant | T/C | snv | 0.19 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.701 | 0.480 | 6 | 31574699 | upstream gene variant | C/A | snv | 0.14 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.776 | 0.320 | 6 | 31572779 | missense variant | T/C | snv | 0.27 | 0.27 |
|
Musculoskeletal Diseases | 0.010 | < 0.001 | 1 | 2017 | 2017 | ||||||
|
0.732 | 0.320 | 6 | 31572364 | 5 prime UTR variant | A/C | snv | 0.64 |
|
Musculoskeletal Diseases | 0.010 | < 0.001 | 1 | 2017 | 2017 | |||||||
|
0.641 | 0.600 | 6 | 31572536 | intron variant | A/G;T | snv |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.608 | 0.760 | 6 | 31574531 | upstream gene variant | T/C | snv | 0.19 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.608 | 0.760 | 6 | 31574531 | upstream gene variant | T/C | snv | 0.19 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.600 | 0.680 | 6 | 31574705 | upstream gene variant | C/T | snv | 8.5E-02 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.200 | 6 | 31571990 | upstream gene variant | C/T | snv | 0.15 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.807 | 0.320 | 6 | 31568447 | upstream gene variant | A/G | snv | 0.64 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 |